Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | EIF4EBP1 | Q13541 | 17/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31268802 | 0.92 | EIF4EBP1 (0.33) | PIK3CDEIF4EBP1CNR1 | |
| SCHEMBL31269249 | 0.90 | PDCD1 (0.34) | PIK3CDCNR1PTGDR2 | |
| SCHEMBL30983499 | 0.89 | EIF4EBP1 (0.33) | PIK3CDEIF4EBP1CNR1 | |
| SCHEMBL30983574 | 0.89 | EIF4EBP1 (0.33) | PIK3CDEIF4EBP1CNR1 | |
| SCHEMBL31268913 | 0.88 | CNR1 (0.34) | PIK3CDCNR1 | |
| SCHEMBL31269134 | 0.87 | PLA2G2A (0.35) | PIK3CDCNR1PTGDR2 | |
| SCHEMBL31269437 | 0.87 | PPARD (0.32) | PIK3CDEIF4EBP1CNR1 | |
| SCHEMBL31269222 | 0.87 | CD274 (0.35) | PIK3CDCNR1PTGDR2 | |
| SCHEMBL31269163 | 0.86 | PLA2G2A (0.35) | PIK3CDCNR1PTGDR2 | |
| SCHEMBL31269118 | 0.86 | ACSL1 (0.36) | PIK3CDEIF4EBP1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024201368-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | ASTRAZENECA AB (SE) | 2024-10-03 | — | — | WO | disclosed |